Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer

NCT01017549 is registered in ClinicalTrials.gov with Xoft, Inc. as lead sponsor.

NCT NCT01017549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01017549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Lead sponsor
Xoft, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 26, 2007
Completion date
May 7, 2016
Enrollment
44 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer